SEATTLE (October 21, 2002)-- A recent study presented at the 67th Annual Scientific Meeting of the American College of Gastroenterology shows that although people with GERD (gastroesophageal reflux disease) experienced a 62 percent decline in the average number of days of acid reduction therapy after surgery, one-half of patients received at least one prescription for acid reduction therapy during the 18 months following surgery. More than 15 million Americans experience daily heartburn symptoms and may suffer from GERD.
"To assess the economic implications of medical versus surgical management of GERD, we analyzed medical costs for patients one year before and 18 months after surgery," said the study's lead author Erin M. Sullivan, Ph.D., of the Boston Scientific Corporation (Natick, MA). "The assumption has been that the one-time cost of surgery is lower than the long-term cost of drugs, but we found that the surgery costs were not offset by the reduction in medication costs during an 18-month follow-up period," said Dr. Sullivan.
The symptoms of GERD are caused when the valve between the stomach and
esophagus allows stomach acid to leak into the esophagus. Some people with GERD opt for surgery when drugs do not help enough or when they want to avoid taking drugs for the rest of their lives. When surgery is successful, the one-way valve between the esophagus and stomach works and GERD symptoms reportedly improve.
The researchers examined data from a national database of publicly and privately insured patients. The records of 123 surgical patients were matched to the records of 246 GERD patients managed without surgery. Patients were matched according to age, sex, and other factors.
Slightly more than one-half (54 percent) of patients were female, and the average age of the subjects was 48 years. To control for inflation, Sullivan and colleagues converted all medical costs to 2001 U.S. dollars.
"During the 18 monthsPage: 1 2 Related medicine news :1
Contact: Melissa Emick
American College of Gastroenterology
. Costs of antidepressants could have funded effective alternatives2
. Costs of caring for elders with dementia3
. Costs of family caregiving for elderly with cancer are significant, often forgotten4
. Costs of treating patients on clinical trials are not higher than costs of standard treatment, study suggests5
. Kidney Transplants From Living Donors Reduce Long-Term Costs Of Care6
. Mayo Clinic Study Finds Costs For Cancer Clinical Trials Comparable To Costs For Standard Treatment7
. Low-Tech Devices, Home Adaptations Preserve Independence, Reduce Health-Care Costs For Physically Frail Elderly8
. Patient Characteristics And The Way Patients Are Treated Have Impact On Hospital Costs Of Liver Transplants9
. Disabilities Dont Raise Insurance Costs10
. Study Indicates That Medicare Costs Are Higher -- And Survival Rate Is Better --At Major Teaching Hospitals Survive Climate Change11
. Nurse Practitioners Reducing Costs, Expanding Care